Hummingbird Bioscience Holdings Limited

formerly Hummingbird Bioscience

Hummingbird Bioscience Holdings Limited is a biotech company in Singapore, Singapore, founded in 2015. It has raised $169.0M across 3 rounds, most recently a $125.0M Series C in 2020 (est.).

Home | Hummingbird Bioscience

Headquarters
Singapore
Employees
51–200
Founded
2015
Business Model
B2B
Total Funding
$169.0M
Last Round
$125.0M Series CJan 2020
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 4 investors for this company. The full record is or through the API.

About

Hummingbird Bioscience is a Singapore-based precision biotherapeutics company founded in 2015 that develops a broad pipeline of novel antibody and antibody-drug conjugate (ADC) therapeutics for cancer and other hard-to-treat diseases. The company applies systems biology and computational approaches to uncover novel disease biology, aiming to deliver deep and durable responses for patients. Its clinical-stage programs include HMBD-001 and HMBD-501, and its board includes representatives from investment firms such as Frazier Life Sciences, Novo Holdings, and Decheng Capital.

Summary

It lists 51–200 employees. It has raised $169.0M in total across 3 rounds, most recently a $125.0M Series C round in 2020 (est.). Investors include Polaris Partners, Novo Holdings A/S and Frazier Healthcare.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series CSeries C2020 (est.)
$125.0M

Sign up to see all 3 events

Funding: Series B through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Hummingbird Bioscience Holdings Limited on Indexed.vc
<a href="https://indexed.vc/companies/hummingbird-bioscience-holdings-limited"><img src="https://indexed.vc/api/badge/company/hummingbird-bioscience-holdings-limited" alt="Hummingbird Bioscience Holdings Limited on Indexed.vc" width="260" height="76" /></a>